News Averoa Receives the CHMP’s Positive Opinion for Xoanacyl to Treat Chronic Kidney DiseaseByDipanshu DixitApril 2, 20250Comments
News The US FDA Grants 510(k) Clearance to Teleflex’s AC3 Range Intra-Aortic Balloon Pump (IABP) for Cardiac Patient MobilityByRidhi RastogiApril 2, 20250Comments
News Apellis Pharmaceuticals Reports the US FDA’s sNDA Acceptance & Priority Review of Empaveli for C3 Glomerulopathy and Primary IC-MPGNByRidhi RastogiApril 2, 20250Comments
News Daiichi Sankyo Reports the First Patient Dosing in P-III (DESTINY-Gastric05) Trial of Enhertu Regimen to Treat G/GEJ CancerByRidhi RastogiApril 2, 20250Comments
News Johnson & Johnson Reports P-III (MARIPOSA) Trial Data of Rybrevant + Lazcluze for EGFRm NSCLCByRidhi RastogiApril 2, 20250Comments
News Axsome Therapeutics Reports Topline Data of P-III (PARADIGM) Trial of Solriamfetol for Major Depressive Disorder (MDD) regardless of Excessive Daytime Sleepiness (EDS)ByRidhi RastogiApril 2, 20250Comments
News Lexicon Enters a Global Licensing Agreement with Novo Nordisk for LX9851ByRidhi RastogiApril 2, 20250Comments
News Organon Acquires Regulatory and Commercial Rights of Tofidence IV Infusion (Biosimilar, Actemra) from BiogenByRidhi RastogiApril 2, 20250Comments
SPOTLIGHT Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram MohanByHimanshu SehgalApril 2, 20250Comments
